Technology driven biopharma player with differentiated portfolio and global presence

Ranked one of the fastest growing and 13th largest pharma player in India
(* as per AIOCD-AWACS March 2023)

Developing India’s first indigenous mRNA vaccine for

Committed to ensure dedicated support in the fight against

Committed to ensure dedicated support in the fight against COVID-19

Know More

Emcure Pharmaceuticals Limited was built with the purpose and core belief of making Effective Medicines to Cure patients enabling them to lead healthier lives

We are a fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of biopharmaceutical products globally. Emcure’s differentiated product portfolio lends an unparalleled competitive advantage establishing its presence in all major therapies in the domestic market. With a presence in over 70 countries, Emcure’s goal is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.

13th Largest Pharma Company in India
9,000+ Employees
70+ Countries with presence

Focus Areas

Established presence in key therapeutic areas

Vitamins, minerals and nutrients
Anti-Retro Virals
mRNA vaccine

Research and Development

Leveraging technology as the key differentiator in the mission to develop products that serve across diverse markets. Emcure’s in-house research and development capabilities span both chemistry and biologics providing a unique synergy to develop innovative solutions

Empowered by the strength of ~500 qualified scientists ably led by industry stalwarts: Dr Mukund Gurjar, Dr Sanjay Singh and Dr Deepak Gondaliya

Presence across 5 dedicated facilities focused towards API, formulation and biotechnology research

Read more


January 9, 2023

Mumbai cops book 12 after death due to spurious injection

December 29, 2022

Diabetes, anaemia detection camps held at Bicholim

December 20, 2022

Emcure conducts oral and health check-up camps for nearly 1000 students in Pune

November 28, 2022

Zuventus first in the world to launch Aviptadil for ARDS commercially

November 25, 2022

Emcure Pharmaceuticals spends Rs. 6 Cr on CSR in FY 2020-21

November 21, 2022

Adoption of QR code to assure quality of pharmaceutical products

Placeholder Image

Life at Emcure

At Emcure, we believe that the success and growth of the company is in the hands of our people. Hence, we are committed towards nurturing talent and providing equal opportunities for their further development.

Join us
Placeholder Image

Uncondition Yourself

Women’s Health continues to be a topic discussed in hushed tones with irrational stigmas and taboos associated with it. This platform aims to share real-life experiences, break myths & taboos and highlight facts, to change the dismal statistics around women’s health.